🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 4 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 14/01/1997 | 57,08 | 57,08 | 54,27 | 54,74 | -2,50% | 4,92% | 52.124 |
| 13/01/1997 | 57,08 | 57,08 | 55,21 | 56,14 | -0,83% | 3,28% | 32.648 |
| 10/01/1997 | 56,14 | 57,08 | 54,27 | 56,61 | +0,83% | 5,00% | 76.276 |
| 09/01/1997 | 57,08 | 58,02 | 53,34 | 56,14 | -1,64% | 8,20% | 74.593 |
| 08/01/1997 | 63,16 | 63,16 | 57,08 | 57,08 | -8,27% | 9,63% | 111.382 |
| 07/01/1997 | 61,29 | 63,63 | 60,82 | 62,23 | +0,76% | 4,58% | 116.191 |
| 06/01/1997 | 59,89 | 62,69 | 59,89 | 61,76 | +3,13% | 4,69% | 118.969 |
| 03/01/1997 | 56,85 | 60,82 | 56,14 | 59,89 | +4,17% | 8,23% | 71.040 |
| 02/01/1997 | 57,08 | 57,55 | 55,21 | 57,49 | +3,26% | 4,10% | 62.464 |
| 31/12/1996 | 55,21 | 58,72 | 55,21 | 55,68 | -0,42% | 6,36% | 76.330 |
| 30/12/1996 | 53,34 | 57,08 | 53,34 | 55,91 | +3,91% | 7,02% | 80.791 |
| 27/12/1996 | 51,00 | 55,68 | 50,53 | 53,81 | +6,48% | 10,09% | 44.403 |
| 26/12/1996 | 51,47 | 51,47 | 49,59 | 50,53 | -0,92% | 3,64% | 19.423 |
| 24/12/1996 | 51,47 | 51,47 | 50,53 | 51,00 | +0,00% | 1,82% | 4.301 |
| 23/12/1996 | 51,47 | 52,40 | 50,53 | 51,00 | -0,91% | 3,64% | 33.529 |
| 20/12/1996 | 53,34 | 54,27 | 51,47 | 51,47 | -2,65% | 5,26% | 28.400 |
| 19/12/1996 | 52,40 | 54,27 | 51,93 | 52,87 | +0,89% | 4,46% | 39.701 |
| 18/12/1996 | 50,53 | 52,40 | 49,59 | 52,40 | +3,70% | 5,56% | 31.526 |
| 17/12/1996 | 53,81 | 54,27 | 49,59 | 50,53 | -3,57% | 8,70% | 83.970 |
| 16/12/1996 | 53,81 | 55,21 | 51,00 | 52,40 | -1,75% | 7,83% | 104.142 |
| 13/12/1996 | 51,93 | 53,81 | 50,53 | 53,34 | +2,70% | 6,31% | 55.891 |
| 12/12/1996 | 51,00 | 51,93 | 49,13 | 51,93 | +2,78% | 5,50% | 80.684 |
| 11/12/1996 | 49,13 | 51,93 | 47,72 | 50,53 | -0,92% | 8,57% | 161.716 |
| 10/12/1996 | 48,19 | 51,00 | 48,19 | 51,00 | +10,10% | 5,83% | 182.502 |
| 09/12/1996 | 45,38 | 46,79 | 44,92 | 46,32 | +2,06% | 4,12% | 203.848 |
| 06/12/1996 | 45,38 | 45,38 | 43,04 | 45,38 | +0,00% | 5,15% | 127.038 |
| 05/12/1996 | 45,38 | 45,38 | 44,45 | 45,38 | +0,00% | 2,06% | 149.961 |
| 04/12/1996 | 45,85 | 46,32 | 43,98 | 45,38 | -1,02% | 5,10% | 82.047 |
| 03/12/1996 | 46,79 | 46,79 | 45,85 | 45,85 | -1,01% | 2,00% | 287.605 |
| 02/12/1996 | 47,26 | 47,26 | 45,85 | 46,32 | +2,59% | 2,97% | 142.266 |